The AMiNDR Team 의 AMiNDR: A Month in Neurodegenerative Disease Research
The AMiNDR Team
This is a podcast made by scientists for scientists, to help you save time so you can conduct better research. For a given month, we sort the abstracts of the latest primary research articles on Alzheimer's disease into separate categories. We then summarize them for you to enjoy on the bus, on your jog, or in the lab. We hope you find our podcast useful and accessible.
카테고리: 과학 및 의학
마지막 에피소드 듣기:
Another series of AMiNDR kicks off with this episode. Anusha takes you through 7 papers published in January 2024 targeting neuroprotection in AD. If you'd like to hear about potential compounds that could reduce neurodegeneration in Alzheimer's disease, this is the episode for you. Testing for neuroprotection in cell lines (2:57) Testing for neuroprotection using in vivo AD models (11:47)
이전 에피소드
-
338 - 339 - Treatments Targeting Neuroprotection in Alzheimer's Disease Tue, 26 Mar 2024
-
337 - 338 - Interview with Joseph Liang - Navigating The Journey To (And Through) Graduate School Tue, 20 Feb 2024
-
336 - 337 - Prevention & Intervention Strategies for AD Wed, 14 Feb 2024
-
335 - 336 - Treatments Targeting Cholinergic Neurotransmission in AD Tue, 6 Feb 2024
-
334 - 335 - A Conversation with Gina Martin: Bringing Visual Awareness to Dementia Mon, 29 Jan 2024
-
333 - 334 -Treatments Targeting Neuroprotection in Alzheimer's Disease Tue, 23 Jan 2024
-
332 - 333 - Cognitive & Behavioural Changes in Alzheimer's Disease: February 2023 Mon, 8 May 2023
-
331 - 332 - Prevention & Intervention Strategies for Alzheimer's Disease: February 2023 Wed, 3 May 2023
-
330 - 331 - Treatments Targeting Neuroprotection in Alzheimer's Disease: February 2023 Tue, 2 May 2023
-
329 - 330 - Vascular Changes in Alzheimer's Disease: January 2023 Tue, 11 Apr 2023
-
328 - 329 - Treatments Targeting Neurotransmission in Alzheimer's Disease: January 2023 Fri, 7 Apr 2023
-
327 - 328 - Functional Connectivity & Imaging in Alzheimer's Disease: January 2023 Tue, 4 Apr 2023
-
326 - 327 - Prevention & Intervention Strategies for Alzheimer's Disease: January 2023 Thu, 30 Mar 2023
-
325 - 326 - Cognitive & Behavioural Changes in Alzheimer's Disease: January 2023 Tue, 28 Mar 2023
-
324 - 325 - Treatments Targeting Neuroprotection in Alzheimer's Disease: January 2023 Thu, 23 Mar 2023
-
323 - 324 - Synaptic Transmission in Alzheimer's Disease: January 2023 Tue, 21 Mar 2023
-
322 - 323 - The Immune System & Glia in Alzheimer's Disease Part 1: November 2022 Thu, 9 Mar 2023
-
321 - 322 - Functional Connectivity & Imaging in Alzheimer's Disease: November 2022 Tue, 7 Mar 2023
-
320 - 321 - Prevention & Intervention Strategies for Alzheimer's Disease: November 2022 Tue, 28 Feb 2023
-
319 - 320 - Treatments Targeting Neuroprotection in Alzheimer's Disease: November 2022 Thu, 23 Feb 2023
-
318 - 319 - Cognitive & Behavioural Changes in Alzheimer's Disease Part 1: November 2022 Tue, 21 Feb 2023
-
317 - 318 - Synaptic Transmission in Alzheimer's Disease: November 2022 Thu, 16 Feb 2023
-
316 - 317 - Functional Connectivity & Imaging in Alzheimer's Disease: October 2022 Fri, 27 Jan 2023
-
315 - 316 - Treatments Targeting Neuroprotection in Alzheimer's Disease: October 2022 Tue, 24 Jan 2023
-
314 - 315 - Cognitive and Behavioural Changes in Alzheimer's Disease: October 2022 Thu, 19 Jan 2023
-
313 - 314 - Vascular Changes in Alzheimer's Disease: October 2022 Tue, 17 Jan 2023
-
312 - 313 - Synaptic Transmission in Alzheimer's Disease: October 2022 Thu, 12 Jan 2023
-
311 - 312 - Prevention & Intervention Strategies for Alzheimer's Disease: August 2022 Thu, 29 Dec 2022
-
310 - 311 - Understanding APOE: August 2022 Thu, 22 Dec 2022
-
309 - 310 - Cognitive and Behavioural Changes in Alzheimer's Disease: August 2022 Thu, 15 Dec 2022
-
308 - 309 - Vascular Changes in Alzheimer's Disease: August 2022 Tue, 13 Dec 2022
-
307 - 308 - Synaptic Transmission in Alzheimer's Disease: August 2022 Thu, 8 Dec 2022
-
306 - 307 - Cognitive & Behavioural Changes in Alzheimer's Disease Part 2: July 2022 Fri, 4 Nov 2022
-
305 - 306 - Prevention and Intervention Strategies for Alzheimer's Disease: July 2022 Tue, 1 Nov 2022
-
304 - 305 - Treatments Targeting Neuroprotection in Alzheimer's Disease: July 2022 Thu, 27 Oct 2022
-
303 - 304 - Understanding APOE: July 2022 Thu, 20 Oct 2022
-
302 - 303 - Cognitive & Behavioural Changes in Alzheimer's Disease Part 1: July 2022 Mon, 17 Oct 2022
-
301 - 302 - Vascular Changes in Alzheimer's Disease: July 2022 Thu, 13 Oct 2022
-
300 - 301 - Synaptic Transmission in Alzheimer's Disease: July 2022 Wed, 12 Oct 2022
-
299 - 300 - Prevention and Intervention Strategies for Alzheimer's Disease: June 2022 Sat, 17 Sep 2022
-
298 - 299 - Cognitive Assessment in Alzheimer's Disease Part 2: June 2022 Thu, 15 Sep 2022
-
297 - 298 - Understanding APOE and Alzheimer's Disease: June 2022 Thu, 8 Sep 2022
-
296 - 297 - Genetic Insights for Alzheimer's Disease: June 2022 Tue, 6 Sep 2022
-
295 - 296 - Treatments Targeting Neuroprotection in Alzheimer's Disease: June 2022 Thu, 1 Sep 2022
-
294 - 295 - Cognitive and Behavioural Changes in Alzheimer's Disease: June 2022 Mon, 29 Aug 2022
-
293 - 294 - Cognitive Assessment in Alzheimer's Disease Part 1: June 2022 Fri, 26 Aug 2022
-
292 - 293 - Vascular Changes in Alzheimer's Disease: June 2022 Wed, 24 Aug 2022
-
291 - 292 - Synaptic Transmission in Alzheimer's Disease: June 2022 Tue, 23 Aug 2022
-
290 - 291 - Vascular Contributions to Alzheimer's Disease: May 2022 Mon, 1 Aug 2022
-
289 - 290 - Treatments Targeting Neuroprotection in Alzheimer's Disease: May 2022 Fri, 29 Jul 2022